Thrombocytopenia in hydropic fetuses with parvovirus B19 infection: incidence, treatment and correlation with fetal B19 viral load.
OBJECTIVE
To examine (1) the incidence of fetal thrombocytopenia in hydropic fetuses with congenital B19 virus infection, (2) the effect of intrauterine platelet transfusions and (3) the correlation between fetal B19 viral load and severity of thrombocytopenia.


METHODS
Retrospective analysis of data from prospectively collected fetal blood samples.


METHODS
Leiden University Medical Centre, the national centre for management of intrauterine fetal disease in the Netherlands.


METHODS
Thirty hydropic fetuses treated with intrauterine red blood cell and platelet transfusions for human B19 virus-induced severe fetal anaemia and thrombocytopenia over a 10-year period.


METHODS
Fetal blood samples (n= 30) taken before and after intrauterine transfusion were investigated. No cases were excluded, and there was no loss to follow up.


METHODS
Parameters recorded were gestational age, experienced fetal movements, gravidity and parity, severity of fetal hydrops, severity of fetal anaemia and thrombocytopenia and megakaryocyte and reticulocyte counts. Survival and procedure-associated complications were documented. Quantitative B19 viral load measurements were performed on all fetal samples.


RESULTS
Forty-six percent of all hydropic fetuses showed severe thrombocytopenia. No antenatal intracerebral haemorrhage or procedure-associated bleeding occurred. Overall, survival was 77%. Platelet counts increased following platelet transfusion and decreased significantly following red blood cell transfusion alone. No correlation was found between fetal viral loads and platelet counts.


CONCLUSIONS
Thrombocytopenia was frequently encountered in fetal B19V infection, but fetal bleeding complications were not noted. Absence of a direct relationship between fetal B19 viral load and platelet counts suggests a temporal dissociation between these findings. Dilutional thrombocytopenia is frequently seen in the fetus following red blood cell transfusion alone. The clinical significance of this phenomenon is unclear. The risk of fluid overload by fetal platelet transfusion in a severely hydropic fetus should be weighed against the low incidence of fetal bleeding complications.
de Haan
T R
TR
Department of Paediatrics, Division of Neonatology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
van den Akker
E S A
ES
Porcelijn
L
L
Oepkes
D
D
Kroes
A C M
AC
Walther
F J
FJ
D000328:Adult; D000740:Anemia / Q000150:complications*; D001792:Blood Platelets / Q000821:virology; D001805:Blood Transfusion, Intrauterine / Q000379:methods; D005260:Female; D005312:Fetal Blood / Q000821:virology; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D015160:Hydrops Fetalis / Q000821:virology*; D007958:Leukocyte Count; D010322:Parvoviridae Infections / Q000150:complications*; D016732:Parvovirus B19, Human; D017713:Platelet Transfusion / Q000379:methods; D011247:Pregnancy; D011446:Prospective Studies; D012189:Retrospective Studies; D013921:Thrombocytopenia / Q000628:therapy / Q000821:virology*; D019562:Viral Load
D006454:Hemoglobins